1. Home
  2. ELTX vs VTSI Comparison

ELTX vs VTSI Comparison

Compare ELTX & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • VTSI
  • Stock Information
  • Founded
  • ELTX 2011
  • VTSI 1993
  • Country
  • ELTX United States
  • VTSI United States
  • Employees
  • ELTX N/A
  • VTSI N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • ELTX Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • ELTX Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • ELTX 121.7M
  • VTSI 67.3M
  • IPO Year
  • ELTX N/A
  • VTSI N/A
  • Fundamental
  • Price
  • ELTX $8.09
  • VTSI $6.25
  • Analyst Decision
  • ELTX Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • ELTX 2
  • VTSI 1
  • Target Price
  • ELTX $9.50
  • VTSI $7.00
  • AVG Volume (30 Days)
  • ELTX 46.9K
  • VTSI 162.6K
  • Earning Date
  • ELTX 08-12-2025
  • VTSI 08-11-2025
  • Dividend Yield
  • ELTX N/A
  • VTSI N/A
  • EPS Growth
  • ELTX N/A
  • VTSI N/A
  • EPS
  • ELTX N/A
  • VTSI 0.19
  • Revenue
  • ELTX N/A
  • VTSI $26,164,645.00
  • Revenue This Year
  • ELTX N/A
  • VTSI $9.92
  • Revenue Next Year
  • ELTX N/A
  • VTSI $16.54
  • P/E Ratio
  • ELTX N/A
  • VTSI $33.18
  • Revenue Growth
  • ELTX N/A
  • VTSI N/A
  • 52 Week Low
  • ELTX $3.70
  • VTSI $3.57
  • 52 Week High
  • ELTX $9.99
  • VTSI $9.40
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 62.14
  • VTSI 49.81
  • Support Level
  • ELTX $7.76
  • VTSI $6.40
  • Resistance Level
  • ELTX $8.94
  • VTSI $6.71
  • Average True Range (ATR)
  • ELTX 0.37
  • VTSI 0.43
  • MACD
  • ELTX -0.03
  • VTSI -0.07
  • Stochastic Oscillator
  • ELTX 51.09
  • VTSI 21.77

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: